These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Listed as ongoing, but also has a completion date 2005-000217-35 EpSSG RMS 2005 a protocol for non metastatic rhabdomyosarcoma 2024-04-19 bad-data
Not reported 2006-004155-38 Biochemical effects of a long-term supplementation with omega-3 polyunsaturated fatty acids in cystic fibrosis 2010-04-30 due-trials
Completed, report not yet due 2006-005789-38 Dexaméthasone et Amygdalectomie 2024-10-01 not-yet-due
Completed, report not yet due 2006-006553-26 Détermination de la MLAC (Minimum Local Analgesic Concentration) pour le Ropivacaine, la Levobupivacaine et la Bupivacaine dans l'analgésie caudale chez l'enfant. 2024-10-01 not-yet-due
Ongoing 2009-014256-30 Une analgésie de choix pour l'intubation des nouveau-nés : Etude multicentrique randomisée comparant le rémifentanil à l'association morphine-midazolam not-yet-due
Completed, report not yet due 2013-003931-30 A prospective open-label study on efficacy and tolerability of colloidal bismuth sub-citrate as adjunctive therapy to a combination of esomeprazole, amoxicillin and metronidazole for 10 days for Helic... 2024-09-16 not-yet-due
Completed, but no date 2014-002221-35 Prospective Randomized Study Comparing the Efficacy and Safety of Pleural Drainage by Video-Assisted Thoracoscopic With Pleural Drain Associated With Urokinase in the Treatment of Parapneumonic Pleura... bad-data
No trial status on register 2014-002306-21 Monocentric, prospective randomized controlled clinical trial assessing the effect on the lower limb spinal motoneuron excitability, the efficacy in term of morphinic sparing and safety of of early c... bad-data
Completed, report not yet due 2021-004456-42 Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for pr... 2024-10-03 not-yet-due